Posted by JLM on December 7, 2002, at 1:52:17
In reply to Lets see what the FDA thinks?, posted by Mr.Scott on December 7, 2002, at 1:34:58
> Thank you for the information. I have forwarded it to the advertising
> division for their evaluation.
>
> Jim Morrison
> CDER Ombudsman
>
>
>
>
>
>
> --------------------------------------------------------------------------------
> Subj: Forest Pharmaceuticals
> Date: Wed, 4 Dec 2002 04:06:23 -0500
> From:
> To: MORRISONJ@CDER.FDA.GOV
>
>
>
> Dear Mr. Morrison of the DDMAC division of the FDA,
>
> There is a well trafficked forum for patients suffering mental illness on
> the
> internet at the address www.dr-bob.org/babble.
>
> Under the posting name of "pharmrep," you will find a self-admitting
> representative for Forest Pharmaceuticals who is disseminating clinical data
> directly to patients on the newly approved SSRI
> Lexapro (escitalopram).
>
> I believe this constitutes a marketing violation in that a self admitting
> pharmaceutical representative for Forest Pharmaceuticals is 'selling' or consulting
> directly to patients without any clear fair balance attached to the information
> being so readily offered. As I understand the regulatory procedure all direct to patient marketing must contain clear fair balance.
>
> While this clever marketing tactic of creating hopes in the minds of the
> suffering with the ultimate goal of influencing physicians prescibing
> habbits
> may not yet have a legal precendent by which your body can make a
> deliberation, I think it is worthy of investigation.
>
> Sincerely and Annonymous.
>
>
>
>
>
>Well, this ought to be interesting to say the least.
I certainly think we are only getting one side of the story, namely Forrest/Lundbecks.
poster:JLM
thread:109458
URL: http://www.dr-bob.org/babble/20021203/msgs/130865.html